Immune-Related Pancytopenia Induced by Anti-PD-1 Therapy – Interrupt or Continue Treatment – The Role of Immunohistochemical Examination

Immune checkpoint inhibitors (ICIs), including anti-cytotoxic T-lymphocyte antigen 4 (anti-CTLA-4) and anti-programmed death receptor-1/ligand-1 (anti-PD-1/anti-PD-L1) caused a breakthrough in oncology and significantly improved therapeutic outcomes in cancer patients. ICIs generate a specific react...

Descripción completa

Detalles Bibliográficos
Autores principales: Cybulska-Stopa, Bożena, Gruchała, Andrzej, Niemiec, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873039/
https://www.ncbi.nlm.nih.gov/pubmed/31762755
http://dx.doi.org/10.1159/000504130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873039/
https://www.ncbi.nlm.nih.gov/pubmed/31762755
http://dx.doi.org/10.1159/000504130

Ejemplares similares